Biosimilars and Biobetters 29 - 30 September 2014, London UK

Impending patent expirations on blockbuster biologics and a volatile financial environment is causing payers to seek wider adoption of biosimilars in order to manage growing healthcare costs. As a result, the biosimilars manufacturing market is set to expand over the next decade and beyond as the drive to find cost-effective alternatives to biologics leads to the growing. In fact analysts predict that between 2013-2018, the global biosimilars market will grow at 27.58 %.

Returning for its fitfth year and following on from the major success of previous events, SMI are proud to present the 5th annual Biosimilars & Biobetters Conference, 29th-30th September, 2014, London. With an in-depth focus on the current and future landscape of the biosimilars market, this meeting will allow input from key industry experts in the field to engage in meaningful and important discussions on how to accelerate drug development to market.

Join us and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding biosimilar commercial and manufacturing developments.

Key topics include:

• Biosimilars, biobetters - the patients perspective
• The big guns are coming! ...how will the entry of originator companies impact the biosimilars industry
• What is on the horizon? ... Reviewing the opportunities and challenges for the biopharmaceutical industry
• Christening day…but what shall we call you! Discussing the ongoing debate on naming biosimilars
• And much more!